ClearPoint Neuro (CLPT) announced the successful completion of the first clinical procedure utilizing the 510(k)-cleared Velocity Alpha MR High Speed Surgical Drill System. “The design of the drill bits provides tactile feedback during bone access, and facilitates consistent, predictable opening of the skull even during minimally invasive procedures where the bone is not fully visualized,” said Paul Larson, chief medical officer of ClearPoint Neuro. “For my cases that involve multiple trajectories, its integration with the SmartFrame platform has the potential to reduce my procedure times by an hour or more.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLPT:
- ClearPoint Neuro announces Canadian approval for Neuro Navigation System
- Clearpoint Neuro’s IRRAS Acquisition: Integration Risks Threaten Promised Scale and Synergies
- ClearPoint Neuro price target raised to $20 from $18 at B. Riley
- Clearpoint Neuro Charts Aggressive Growth Amid Rising Costs
- ClearPoint Neuro Reports Record 2025 Results, Expands Growth Outlook
